Back to search results

Study of 3M™ Ioban™ CHG Incise Drape in Hip and Knee Replacement Surgery

This study is testing a special antibacterial skin covering called 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape. This drape is placed on your skin before surgery to help prevent infections. We want to see how well it works to reduce contamination (unwanted germs) at the surgical site during hip or knee replacement surgery. You can join if you are at least 22 years old and are having your first hip or knee replacement. The study will measure if any contamination is present during your surgery. The current status of the study is unclear, and it plans to include 179 participants.

Study design
This is a single-arm study, meaning all participants will receive the same intervention. It will include 179 participants undergoing hip or knee replacement surgery.
What's involved
You would have the 3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape applied during your surgery. Samples will be collected from your surgical site during the procedure to check for contamination.
Compensation
Not stated in the trial record.
Follow-up
The primary measurement for contamination is taken during surgery. It is not specified if there are follow-up visits after this.

AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.

NCT07356323

A Prospective, Single-arm, Trial to Determine Contamination Rates When Using an Antibacterial Incise Drape During Orthopedic Surgery

Recruiting
NAAges 22+InterventionalPrevention
Solventum US LLC
~179 participants
Updated 2026-07-01 on ClinicalTrials.gov
What's tested:3M™ Ioban™ CHG Chlorhexidine Gluconate Incise Drape (2% w/w CHG)

At a glance

Recruiting sites
2 of 2 listed sites are recruiting right now
RecruitingSuspended, closed, or not yet open
What they're measuring
Evaluation of the presence of contamination at the surgical site during the operative procedure.
Measured over During surgery

Conditions

Arthroplasty Replacement, Knee
Arthroplasty Total Hip Replacement

Explore related trials

Repair of hipTotal Knee Replacement

Where it's being run

2 sites across 2 states
Indiana1
Utah1

Who to contact

Tracy E Swanson
[email protected]
6125417752
Email the study team

Opens a ready-to-send draft in your own email app — review before sending.

Do you actually qualify for this trial?

Add a private profile and we'll compare every criterion below against your situation — and tell you which ones are met, uncertain, or excluding.

Check eligibility for this trial ~2 min · HIPAA-protected · delete anytime
Eligibility criteria

Inclusion

Subject is ≥ 22 years of age on the day of surgery.
Subject is scheduled to undergo a unilateral primary arthroplasty procedure on a hip or knee.
Subject is capable of providing informed consent.
Subject is willing and able to return for all visits.

Exclusion

Subject is pregnant or lactating prior to surgery.\*
Subject is scheduled to undergo a lower extremity bilateral arthroplasty procedure.
Subject had a previous open knee surgery on the study knee or is scheduled to undergo a revision knee arthroplasty.
Subject has had a previous surgery for revision femoral acetabular osteotomy or total hip arthroplasty on the study hip.
Subject is scheduled for lower extremity arthroplasty due to trauma.
Subject was previously diagnosed with septic arthritis or has a history of infection in the joint.
Subject has taken any antibiotics within 4 weeks before surgery.
Subject has an allergy or sensitivity to components of the device (e.g., chlorhexidine gluconate or acrylate-based adhesive).
Subject is currently enrolled in another trial.

What this trial measures

  • Evaluation of the presence of contamination at the surgical site during the operative procedure.During surgery

    Assessment of contamination at the surgical site during the operative procedure.